SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-24-018785
Filing Date
2024-04-29
Accepted
2024-04-29 08:03:27
Documents
23
Period of Report
2024-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A cccc-20240429.htm   iXBRL DEF 14A 838993
3 cccc-20240429_g1.jpg GRAPHIC 50977
4 cccc-20240429_g10.jpg GRAPHIC 107724
5 cccc-20240429_g11.jpg GRAPHIC 99935
6 cccc-20240429_g12.jpg GRAPHIC 25403
7 cccc-20240429_g2.jpg GRAPHIC 30489
8 cccc-20240429_g3.jpg GRAPHIC 39259
9 cccc-20240429_g4.jpg GRAPHIC 30171
10 cccc-20240429_g5.jpg GRAPHIC 3825
11 cccc-20240429_g6.jpg GRAPHIC 2886
12 cccc-20240429_g7.jpg GRAPHIC 2218
13 cccc-20240429_g8.jpg GRAPHIC 45935
14 cccc-20240429_g9.jpg GRAPHIC 45658
  Complete submission text file 0001628280-24-018785.txt   2568449

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cccc-20240429.xsd EX-101.SCH 928
26 EXTRACTED XBRL INSTANCE DOCUMENT cccc-20240429_htm.xml XML 123319
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39567 | Film No.: 24886672
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)